John Haurum, formerly chief executive of the UK biotech F-star, has been named executive chairman of Synklino ApS. Based in Copenhagen, Denmark, Synklino is developing therapies to treat cytomegalovirus infections in transplant patients. Dr Haurum led drug discovery at F-star while helping raise more than €200 million in equity and non-dilutive funding for the company.
Synklino ApS announced the appointment on 3 January 2019.
Copyright 2019 Evernow Publishing Ltd